DALIAN HANDOM CHEM: GLP-1 import refusal records

Has FDA refused imports of GLP-1 products from DALIAN HANDOM CHEM?

Yes. FDA’s import refusal records list 1 refused shipment line declared as made by DALIAN HANDOM CHEM (China) whose FDA product code names semaglutide, on Feb 13, 2024. None of them carries a product code that FDA’s Import Alert 66-80 lists as a GLP-1 API or powder form.

Country
China
City in FDA records
Dalian
FEI numbers on the lines
3030125969
Refused lines
1
Lines with an Import Alert 66-80 API or powder code
0
Drugs named in the product codes
Semaglutide
Refusal dates
Feb 13, 2024

The declared manufacturer is the firm named on the import entry. A refusal is FDA’s decision on one shipment line; it is not a finding about the firm’s other products.

Import Alert 66-80’s Green List (published Oct 9, 2026) prints a redaction in place of every firm name, so this index cannot say whether DALIAN HANDOM CHEM is on it.

Refused shipment lines

FDA refusal chargesShipment ID
Feb 13, 2024China61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80FRNMFGREG: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. Based on information available to FDA, it appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under Section 510 of the Act.799-8922794-7/11/1

FDA refusal charges on these lines

A line can carry several charges. Text is FDA’s charge statement, verbatim.

FRNMFGREG: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. Based on information available to FDA, it appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under Section 510 of the Act.1

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.

1 line from FDA files read Nov 15, 2026.